April 9, 2013 ~  Doctors say their credo is to put patients first.  Why then do so many women talk about the conversations they have with their doctors after they start to feel their implanted mesh is causing complications and not providing a cure?   Across the board doctors say something like this:         “It’s not
[continue reading...]

April 9, 2013 ~ Dr. Robert Bendavid  is a well-known hernia surgeon who in this editorial for the Africa Middle East  Hernia Society discusses surgical mesh. Past president and a founding father of the American Hernia Society, Dr. Bendavid has performed thousands of procedures and is presently associated with the Shouldice Hospital in Toronto where the natural tissue, mesh-free,
[continue reading...]

April 9, 2013 ~ According to a new page on the FDA’s website (here), a public workshop will be held on HoW to Improve the Health of Women (HoW).  The purpose is to delve into how some medical devices work differently in women than men. It’s been noted that some hip implants have an early
[continue reading...]

April 3, 2013 ~ Dr. Anthony Visco is Chief of Urogynecology at Duke Univ. Medical Center and President of AUGS.  The American Urogynecologic Society (AUGS) was founded in 1979 and is a professional organization of 1,400 physicians and allied health professionals who care for women with pelvic floor disorders, specifically pelvic organ prolapse (POP) and
[continue reading...]

  Some Highlights from the AUGS Informed Consent Toolkit, September 8-9, 2011 “At this time, AUGS does not support the routine use of transvaginal mesh for the repair of POP.” “Given the potential risks, AUGS suggest future placement of transvaginal mesh for POP repair should be judicious and be performed only by surgeons with appropriate
[continue reading...]

March 29, 2013 ~ In September 2011, the U.S. Food and Drug Administration convened a panel of experts to try and get a handle on the concerning number of complications the agency was receiving about surgical mesh used to treat pelvic organ prolapse (POP)  and stress urinary incontinence (SUI).  The experts  suggested that because of the
[continue reading...]

March 26, 2013~  Today, the American Urogynecologic Society (AUGS) issued a position statement strongly opposing restrictions that ban surgical options for the treatment of pelvic organ prolapse (POP), including transvaginal surgical mesh cleared for use by the U.S. Food and Drug Administration (FDA). The AUGS position states that it is essential for patients and their
[continue reading...]

March 25, 2013~ First Coast News Jacksonville has just aired the latest mesh complication story at its Gannett station. See the story here. “The pain was severe enough that I couldn’t stay still on the bed.”  “It just became unbearable.  I went into seclusion from this.“ These are some of the comments from the four
[continue reading...]

March 22, 2013 ~ Friday night, March 22, Public Broadcasting (PBS) looks into the U.S. Food and Drug Administration (FDA) oversight of medical devices and how so many enter the market with little review and oversight. The 510(k) process allows devices on the market after the manufacturer requests clearance from the FDA and names a
[continue reading...]

March 22, 2013 ~ by ADAM SLATER   Mr. Slater of Mazie, Slater Katz & Freeman LLC of Roseland, New Jersey recently represented plaintiff Linda Gross in her product liability lawsuit against Johnson & Johnson over its Prolift surgical mesh used to treat prolapse.  She was awarded  $3.35 in compensatory damages and $7.76 million in
[continue reading...]